
Trident Lifeline (TLL) | Stock Overview & Key Data
Trident Lifeline Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹339.00 on September 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Trident Lifeline TLL | 3.51B Small-cap | -0.28% | 3.70% | 3.70% | 8.61% | -1.41% | -12.38% | 120.30% | 120.30% |
Medplus Health MEDPLUS | 100.60B Mid-cap | 1.62% | 1.56% | -2.77% | 20.65% | -0.47% | 26.51% | 31.93% | -21.51% |
Sastasundar Ventures SASTASUNDR | 9.77B Small-cap | 6.46% | 12.50% | 1.42% | 29.07% | -3.27% | 1.09% | -6.61% | 272.55% |
One Global Service ONEGLOBAL | 1.87B Small-cap | -2.79% | -8.87% | 2.58% | -11.33% | -21.12% | 81.93% | 670.68% | 6,030.38% |
Murae Organisor MURAE | 1.31B Small-cap | 14.06% | 23.73% | -24.74% | 10.61% | -25.51% | 21.67% | -41.60% | -76.83% |
Achyut Healthcare ACHYUT | 1.26B Small-cap | -0.38% | 0.38% | 44.66% | 62.46% | 27.23% | -89.54% | -72.92% | -72.92% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TLL's 52-week high and low?
- In the last 52 weeks, Trident Lifeline reached a high of ₹334.00 (on October 3, 2024) and a low of ₹222.00 (on March 4, 2025).
- What is the market cap and P/E ratio for TLL?
- Curious about Trident Lifeline's size and valuation? Its market capitalization stands at 3.51B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.44, and the forward P/E (looking ahead) is N/A.
- Does TLL pay dividends? If so, what's the yield?
- As for dividends, Trident Lifeline isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Trident Lifeline's main competitors or similar companies to consider before investing?
When looking at Trident Lifeline, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Medplus Health
MEDPLUS100.60B Healthcare Pharmaceutical Retailers 26.51% 31.93% Sastasundar Ventures
SASTASUNDR9.77B Healthcare Pharmaceutical Retailers 1.09% -6.61% One Global Service
ONEGLOBAL1.87B Healthcare Pharmaceutical Retailers 81.93% 670.68% Murae Organisor
MURAE1.31B Healthcare Pharmaceutical Retailers 21.67% -41.60% Achyut Healthcare
ACHYUT1.26B Healthcare Pharmaceutical Retailers -89.54% -72.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Trident Lifeline Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Trident Lifeline's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.87%, the Debt to Equity ratio from the most recent quarter is 77.58, and its Gross Profit Margin stands at 53.63%.
- What is the recent revenue and earnings growth for TLL?
- Looking at Trident Lifeline's growth, its revenue over the trailing twelve months (TTM) was INR974M. Compared to the same quarter last year (YoY), quarterly revenue grew by 79.50%, and quarterly earnings saw a YoY growth of 73.90%.
- How much of TLL stock is held by insiders and institutions?
- Wondering who owns Trident Lifeline stock? Company insiders (like executives and directors) hold about 77.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.